Veltuzumab (IMMU-106), a humanized anti-CD20 monoclonal antibody, exhibits a low EC50 value ranging from 0.08 to 0.09 µg/mL in the Daudi cell line. It is used in cancer research, specifically for non-Hodgkin lymphoma (NHL) [1].
CAS Number:
[728917-18-8]
* VAT and and shipping costs not included. Errors and price changes excepted